Ekso Bionics (EKSO) Misses Q1 EPS by 2c

Ekso Bionics (NASDAQ: EKSO) reported Q1 EPS of ($0.13), $0.02 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $2.98 million.

For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)
• UBS Reiterates Buy Rating on General Motors (GM) as Defense Opportunity in Focus